230
Participants
Start Date
November 25, 2020
Primary Completion Date
August 31, 2023
Study Completion Date
December 31, 2028
XVIVO heart preservation devices
The intervention is to preserve hearts during transportation cold, cardioplegic and non-ischemic, with a high oncotic and hormone supplemented perfusate.
Standard ICSS
Cold static preservation using standard preservation solution
UZ Leuven, Leuven
Deutschen Herzzentrum Berlin, Berlin
Hospital Puerto de Hierro, Madrid
Azienda osedalaria di Padova, Padua
Institut de cardiologie, Chirurgie thoracique et cardiovasculaire La Pitié Salpetrière, Paris
Klinikum der Universität München, München
Allgemeines Krankenhaus der Stadt Wien, Vienna
Hôpital Bichat Claude-Bernard, Paris
Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen
Universitätsklinikum Düsseldorf, Düsseldorf
Hannover Medical School, Hanover
Royal Papworth Hospital, Cambridge
Sahlgrenska University Hospital, Gothenburg
Freeman Hospital, Newcastle
Queen Elisabeth Hospital, Birmingham
XVIVO Perfusion
INDUSTRY